CN
Genecast presented 3 studies at ASCO 2025，including 1 posters, 2 online abstracts：
| ID | Title |
| 482 | Prognostic value of postoperative circulating tumor DNA and tumor markers in resected pancreatic adenocarcinoma (PAAD): an interim analysis of a prospective observational study |
| e18090 | Prospective validation of dynamic circulating tumor DNA (ctDNA)-based MRD for predicting progression-free survival and treatment benefit in oral cancer |
| e23535 | Efficacy and molecular predictors of radiotherapy combined with bevacizumab on desmoid tumor (aggressive fibromatosis) |
#02-01/02, The Kendall, 50 Science Park Road. Singapore Science Park 2, Singapore 117406
Tel: +65 6047 0252 ; Email: info@genecast.com.sg
Copyright © 2014-2026 Genecast Group Inc. | Privacy Policy
